All News

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 2 min read

The US Federal Reserve is preparing for its next Federal Open Market Committee (FOMC) meeting, set to take place over two days starting from March 18, 2025. The highly anticipated meeting comes amid market uncertainty caused by US President Donald Tr

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Emerging market equities are on track to extend their strongest monthly performance in half a year, driven by a resurgence in Chinese stocks fueled by increased fiscal measures. The MSCI Emerging Markets Index has climbed nearly 3 in March, marki

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

India's trade deficit declined to $14.05 billion in February, marking a significant drop from January’s $22.9 billion. This reduction surpassed economists' expectations, as a Reuters poll had projected the deficit to ease to $21.65 billion. Merc

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 4 min read

Market participants have responded positively to the National Stock Exchange’s (NSE) recent directive prohibiting order confirmations through interactive voice response (IVR) systems. Sources informed Moneycontrol that the IVR-based confirmation

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 4 min read

The world's largest stock market has experienced a significant downturn in recent weeks, as investor confidence remains shaky due to mounting fears that Donald Trump's trade disputes with key trading allies could negatively impact the economy. These

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Shares of IndusInd Bank climbed 5 to ₹707 on the BSE during Monday’s intra-day trading after the Reserve Bank of India (RBI) reassured depositors about the private lender’s financial health. The reassurance came in the wake of an accounting er

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Allchem Lifescience, a Gujarat-based manufacturer specializing in active pharmaceutical ingredient (API) intermediates and specialty chemicals, has filed draft documents with the Securities and Exchange Board of India (SEBI) seeking approval for an i

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

The Securities and Exchange Board of India (SEBI) is in the process of finalizing a standard operating procedure (SOP) for implementing settlement regulations, given the increasing number of settlement cases. Additionally, SEBI aims to ensure unif

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Jefferies, a global broking firm, has initiated coverage on Patanjali Foods with a positive 'buy' rating, highlighting its transformation into a diversified consumer franchise. The brokerage has set a target price of ₹2,050 per share, suggesting

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

G R Infraprojects Ltd. is set to break its four-day losing streak on March 17, following a major project win from the National Highways Authority of India (NHAI). The infrastructure firm has been selected as the preferred bidder for a ₹4,2

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Foreign investors have continued to withdraw funds from the Indian equity market, pulling out over ₹30,000 crore in the first half of the month due to escalating global trade tensions. This follows withdrawals of ₹34,574 crore in February and

Generic user silhouette icon 5paisa Capital Ltd
  • 17th Mar 2025
  • 3 min read

Gold prices in India have shown a slight decline today, 17th March 2025, after a period of notable volatility over the past week. After witnessing a significant surge on Friday, gold prices have experienced a mild correction. As per the latest market

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form